Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
44%

OVERLAP
BY WEIGHT
11

# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
41%
ALSO IN XLV
XLV
59
HOLDINGS
19%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus XLV)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in XLV
Overlap
ELI LILLY & CO 17.5% 14.7% 14.7%
ABBVIE INC 8.9% 7.3% 7.3%
JOHNSON & JOHNSON 6.0% 10.7% 6.0%
MERCK & CO. INC. 4.6% 6.0% 4.6%
AMGEN INC 4.7% 3.8% 3.8%
MEDX Overweight Relative to XLV
NOVARTIS AG-ADR 7.0%
ALKERMES PLC 4.8%
ASTRAZENECA PLC 4.2%
IONIS PHARMACEUTICALS, INC. 3.3%
ALNYLAM PHARMACEUTICALS INC 3.0%
ELI LILLY & CO 2.8%
CRISPR THERAPEUTICS AG 2.7%
BIOGEN IDEC INC 2.6%
GLAXOSMITHKLINE PLC-SPON ADR 2.5%
BRISTOL-MYERS SQUIBB CO 2.4%
MEDX Underweight Relative to XLV
UNITEDHEALTH GROUP INC -5.8%
JOHNSON & JOHNSON -4.7%
THERMO FISHER SCIENTIFIC INC -3.7%
ABBOTT LABORATORIES -3.1%
GILEAD SCIENCES INC -3.0%
VERTEX PHARMACEUTICALS INC -2.2%
DANAHER CORP -2.1%
INTUITIVE SURGICAL INC -2.1%
CVS CAREMARK CORP -2.0%
MEDTRONIC PLC -2.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY